Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

ID Jung, SK Jeong, CM Lee, KT Noh, DR Heo, YK Shin… - Cancer Research, 2011 - AACR
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …
被引用次数：89 相关文章

Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist

ID Jung, SK Jeong, CM Lee, KT Noh… - Cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …

Enhanced efficacy of therapeutic cancer vaccines produced by Co-treatment with mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist

D Jung, SK Jeong, CM Lee, KT Noh… - Cancer …, 2011 - yonsei.elsevierpure.com
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DCbased antitumor immunotherapy, helping promote the development of …
[PDF] archive.org

[PDF][PDF] Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

ID Jung, SK Jeong, CM Lee, KT Noh, DR Heo… - Cancer Res, 2011 - scholar.archive.org
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …

[引用][C] Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

INDUK JUNG, SOOK JEONG, HJ KIM… - Cancer research …, 2011 - pascal-francis.inist.fr
Author IN DUK JUNG 1; SOO KYUNG JEONG 1; KIM, Hwa-Jung 6; WON SUN PARK 7;
SUNG JAE SHIN 6; PARK, Yeong-Min 1; LEE, Chang-Min 1; KYUNG TAE NOH 1; DEOK …

Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

ID Jung, SK Jeong, CM Lee, KT Noh… - CANCER …, 2011 - scholarworks.bwise.kr
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …
[PDF] researchgate.net

[PDF][PDF] Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

ID Jung, SK Jeong, CM Lee, KT Noh, DR Heo… - Cancer Res, 2011 - researchgate.net
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …

Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.

ID Jung, SK Jeong, CM Lee, KT Noh, DR Heo… - Cancer …, 2011 - europepmc.org
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …
[PDF] semanticscholar.org

[PDF][PDF] Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

ID Jung, SK Jeong, CM Lee, KT Noh, DR Heo… - Cancer …, 2011 - pdfs.semanticscholar.org
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …

Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 …

ID Jung, SK Jeong, CM Lee, KT Noh… - CANCER …, 2011 - scholarworks.bwise.kr
Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would
improve DC-based antitumor immunotherapy, helping promote the development of …